Tech Company Financing Transactions
Karyopharm Therapeutics Funding Round
On 5/20/2013, Karyopharm Therapeutics raised $48.2 million in Series B investment from private investors and Delphi Ventures.
Transaction Overview
Company Name
Announced On
5/20/2013
Transaction Type
Venture Equity
Amount
$48,200,000
Round
Series B
Investors
private investors (Lead Investor)
Delphi Ventures (Deepa Pakianathan)
Proceeds Purpose
The funds will be used to advance the Company's pipeline of novel Selective Inhibitors of Nuclear Export (SINE) drug candidates for the treatment of advanced hematologic and solid tumors.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
85 Wells Ave. 2nd Floor
Newton, MA 02459
USA
Newton, MA 02459
USA
Phone
Website
Email Address
Overview
Karyopharm Therapeutics is a biopharmaceutical company focusing on the development of novel drugs for the treatment of cancer, inflammation and diseases related to cell proliferation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Kauffman
Chief Operating Officer
Ran Frenkel
Chief Scientific Officer
Sharon Shacham
Vice President
Brian Austad
VP - General Counsel
Christopher Primiano
VP - Operations
Ronit Milstein
Browse more venture capital transactions:
Prev: 5/20/2013: InVisionApp venture capital transaction
Next: 5/20/2013: WiserTogether venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs